Valuation: CellaVision AB

Capitalization 4.96B 455M 430M 399M 357M 643M 38.49B 711M 1.83B 15.82B 1.71B 1.67B 68.14B P/E ratio 2024 *
34x
P/E ratio 2025 * 25.3x
Enterprise value 4.83B 442M 418M 388M 347M 625M 37.45B 692M 1.78B 15.39B 1.66B 1.62B 66.3B EV / Sales 2024 *
6.5x
EV / Sales 2025 * 5.6x
Free-Float
82.65%
Yield 2024 *
1.16%
Yield 2025 * 1.43%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.42%
1 week-4.81%
Current month-4.81%
1 month-13.87%
3 months-22.96%
6 months-19.07%
Current year-1.89%
More quotes
1 week
204.00
Extreme 204
219.00
1 month
204.00
Extreme 204
251.00
Current year
185.20
Extreme 185.2
302.00
1 year
167.20
Extreme 167.2
302.00
3 years
120.00
Extreme 120
394.50
5 years
120.00
Extreme 120
503.50
10 years
36.10
Extreme 36.1
503.50
More quotes
Director TitleAgeSince
Chief Executive Officer 53 20/03/2021
Chief Executive Officer 58 27/11/2020
Investor Relations Contact - -
Manager TitleAgeSince
Director/Board Member 59 -
Director/Board Member 60 03/05/2018
Chairman 62 28/04/2021
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-1.42%-4.81%+20.79%-34.05%455M
+0.19%-2.43%-27.18%-61.49%14.12B
+1.60%-6.83%-42.86%-72.66%2.57B
+5.62%+6.94%-12.13% - 1.5B
+2.98%+2.19%-20.19%+210.94%1.41B
-0.74%+5.58%+27.62%-35.00%1.18B
+1.96%+3.34%-24.42%-60.17%889M
+0.96%-2.62%-28.10%+38.82%873M
-0.43%+1.10%+16.23%-48.55%773M
-1.87%-5.76%-15.44%-45.21%646M
Average +0.89%-1.60%-10.57%-11.93% 2.44B
Weighted average by Cap. +0.78%-2.07%-22.21%-39.26%
See all sector performances

Financials

2024 *2025 *
Net sales 742M 68.02M 64.37M 59.67M 53.36M 96.17M 5.76B 106M 274M 2.37B 256M 250M 10.2B 849M 77.78M 73.6M 68.23M 61.02M 110M 6.59B 122M 314M 2.71B 292M 286M 11.66B
Net income 146M 13.38M 12.67M 11.74M 10.5M 18.92M 1.13B 20.95M 54.01M 466M 50.28M 49.16M 2.01B 196M 17.94M 16.98M 15.74M 14.08M 25.37M 1.52B 28.09M 72.41M 624M 67.41M 65.91M 2.69B
Net Debt -135M -12.32M -11.66M -10.81M -9.67M -17.42M -1.04B -19.29M -49.73M -429M -46.29M -45.26M -1.85B -210M -19.2M -18.17M -16.85M -15.07M -27.15M -1.63B -30.06M -77.5M -668M -72.14M -70.54M -2.88B
More financial data * Estimated data
Logo CellaVision AB
CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The Company operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.
Employees
0
Calendar
More about the company
Date Price Change Volume
06/12/24 208.00 kr -1.42% 92,987
05/12/24 211.00 kr -0.47% 7,586
04/12/24 212.00 kr -0.93% 116,479
03/12/24 214.00 kr -0.47% 8,796
02/12/24 215.00 kr -1.60% 23,305

Delayed Quote Nasdaq Stockholm, December 06, 2024 at 05:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
C+
surperformance-ratings-light-chart CELLAVISION-ABMore Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
208.00SEK
Average target price
270.00SEK
Spread / Average Target
+29.81%
Consensus

Quarterly revenue - Rate of surprise